Related Experiment Video
Updated: Jan 10, 2026

A High-throughput Cell Microarray Platform for Correlative Analysis of Cell Differentiation and Traction Forces
Published on: March 1, 2017
Development of FBXO22 Degraders and the Recruitment Ligand 2-Pyridinecarboxyaldehyde (2-PCA)
Tian Qiu1, Zhe Zhuang1, Woong Sub Byun1
1Department of Chemical and Systems Biology, ChEM-H and Stanford Cancer Institute, Stanford Medical School, Stanford University, Stanford, California 94305, United States.
Abstract:
Targeted protein degradation (TPD) is a promising therapeutic strategy that requires the discovery of small molecules that induce the proximity between E3 ubiquitin ligases and proteins of interest. FBXO22 is an E3 ligase that is overexpressed in many cancers and implicated in tumorigenesis. While FBXO22 was previously identified as capable of recognizing ligands bearing a primary amine degron, further investigation and development of recruitment ligands are required to enable its broader utility for TPD. Here, we describe the discovery of chemical probes that can either selectively degrade FBXO22 or recruit this ligase for TPD applications. First, we described AHPC(Me)-C6-NH2 as a potent and selective FBXO22 degrader (DC50 = 77 nM, Dmax = 99%) that is suitable for interrogating the effects of FBXO22 loss of function. Further, we discovered that the simple hexane-1,6-diamine acts as a minimal FBXO22 self-degrader, whereas shorter C4 (putrescine) to C5 (cadaverine) analogs, found in mammalian cells, do not induce degradation. Finally, we found that 2-pyridinecarboxaldehyde (2-PCA) functions as a novel electrophilic degron capable of forming a reversible thioacetal with cysteine 326 for recruiting FBXO22. Conjugating 2-PCA to various ligands successfully induced the FBXO22-dependent degradation of BRD4 and CDK12. Collectively, these chemical probes will facilitate the study of FBXO22 biology and broaden its applicability in the TPD.
Insights
Researchers developed novel chemical probes for targeted protein degradation (TPD). These probes enable selective degradation of FBXO22 or recruit it for TPD applications, advancing cancer therapy research.
Area of Science:
- Biochemistry
- Chemical Biology
- Drug Discovery
Background:
- Targeted protein degradation (TPD) is a therapeutic strategy.
- FBXO22 is an E3 ligase overexpressed in cancers.
- Developing ligands for FBXO22 is crucial for TPD.
Purpose of the Study:
- Discover chemical probes for FBXO22 degradation.
- Develop ligands to recruit FBXO22 for TPD.
- Investigate FBXO22's role in cancer.
Main Methods:
- Synthesis of FBXO22 degraders and recruiters.
- Biochemical assays to measure degradation.
- Chemical probe conjugation and validation.
Main Results:
- AHPC(Me)-C6-NH2 selectively degrades FBXO22 (DC50 = 77 nM).
- Hexane-1,6-diamine acts as a minimal FBXO22 self-degrader.
- 2-pyridinecarboxaldehyde (2-PCA) recruits FBXO22 via a thioacetal linkage, degrading BRD4 and CDK12.
Conclusions:
- Novel chemical probes advance FBXO22-targeted protein degradation.
- These probes facilitate FBXO22 biology studies.
- Expanded FBXO22 utility in TPD applications.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Export of Misfolded Proteins out of the ER
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
GPCR Desensitization

